Montenegro

Is CBD Legal in Montenegro?

Status

Restricted

Covers

CBD

Jurisdiction

Independent Country

Last updated

August 6, 2026

The short answer

CBD sits in a restricted gray zone in Montenegro. The Agency for Medicines and Medical Devices of Montenegro (CALIMS) treats cannabidiol products with therapeutic claims as unregistered medicines, and no CBD product has received marketing authorization. The Ministry of Agriculture, Forestry and Water Management does not separately regulate cannabidiol-derived consumer goods.

Cosmetic CBD topicals meeting EU-style standards may circulate, but ingestible oils and tinctures face seizure under the Law on the Prevention of Abuse of Narcotic Drugs if THC is detected. Sellers may face administrative penalties under the Consumer Protection Law and criminal liability under Criminal Code Article 300 if products are deemed narcotic. CALIMS has not authorized Epidyolex or other cannabidiol medicines for the Montenegrin market.

Imports through Podgorica Airport and the Port of Bar are routinely held by customs, and online purchases frequently fail to clear.

Last reviewed: August 6, 2026.

This page is for informational purposes only and does not constitute legal advice. Verify current law with qualified counsel before making compliance decisions.

Key facts ·

Montenegro

Key facts

Rules at a glance

All countries

THC limit

Zero detectable THC; no authorized therapeutic products

Regulator

Agency for Medicines and Medical Devices (CALIMS); Ministry of Health

Key regulation

Law on Medicines and Medical Devices; Narcotic Drugs Prevention Law

Effective

January 1, 2022

Adult-use cannabis

Illegal

Medical cannabis

Illegal

For brands and importers

Import and export rules

Commercial CBD import requires CALIMS authorization, which has not been granted for any product. Personal shipments seized at Podgorica Airport. As a non-EU country, Montenegro applies customs duties and full narcotic-control scrutiny to incoming cannabinoid products.

FAQ

Common questions

Latest

Latest news and analysis

All news
No items found.